Donguibogam Evidence Bridge한국어

Rhubarb 大黃

Pharmaceutical nameRhei Radix et Rhizoma

Evidence grade: Preclinical onlyauto-proposed · unreviewedSafety signal: Adverse-event literature existsMapping confidence: Strong correspondence

The three axes are assessed independently and are never combined into a single score.

KTKP records the origin species as Rheum palmatum L.. It has not yet been cross-checked against the Korean Pharmacopoeia, so the identification confidence is not raised to an official code mapping. The same source species also yields 1 other separately registered drug(s) (Rhei Rhizoma), which must not be conflated. The name most used for this taxon in current literature is Rheum palmatum.

Tradition · what the text describes

탕액편

The sub-section within this volume has not been verified against the original text yet.

The KTKP traditional materia medica record (M0000511) gives the origin species as Rheum palmatum L., the part used as 뿌리, 뿌리줄기, and the properties as 고(苦), 한(寒). It lists 간(肝), 대장(大腸), 위(胃) as the channels entered. The same record cites the Donguibogam (1613) as the source for its indications.

Properties & channel entry: 고(苦), 한(寒) · 간(肝), 대장(大腸), 위(胃)

Source species: Rheum palmatum L. (뿌리, 뿌리줄기)

Read the original: Korean Medicine Classics DB ↗

Modern · documented evidence

Diabetic Kidney Diseaseevidence for this indication

Evidence grade: Preclinical onlyauto-proposed · unreviewed
  • 4 registered trial(s) exist but no published systematic review or RCT was found. Check whether the research is ongoing or simply unpublished.
  • The indication was derived automatically from the Condition field of 4 registered trial(s). It reflects what is currently being studied, not a traditional use, and a curator should confirm the label is apt.

Literature

SR 0 · RCT 0 · preclinical 1

No human clinical literature found; 1 preclinical (in vitro/animal) record(s) only.

Query used

We publish the exact query behind these counts so you can reproduce them yourself.

SRC:MED AND ((TITLE_ABS:"Rheum palmatum")) AND TITLE_ABS:"Diabetic Kidney Disease"

Clinical trials

Strokeevidence for this indication

Evidence grade: Preclinical onlyauto-proposed · unreviewed
  • 3 registered trial(s) exist but no published systematic review or RCT was found. Check whether the research is ongoing or simply unpublished.
  • The indication was derived automatically from the Condition field of 3 registered trial(s). It reflects what is currently being studied, not a traditional use, and a curator should confirm the label is apt.

Literature

SR 0 · RCT 0 · preclinical 2

No human clinical literature found; 2 preclinical (in vitro/animal) record(s) only.

Query used

We publish the exact query behind these counts so you can reproduce them yourself.

SRC:MED AND ((TITLE_ABS:"Rheum palmatum")) AND TITLE_ABS:"Stroke"

Clinical trials

Sepsisevidence for this indication

Evidence grade: Promisingauto-proposed · unreviewed
  • The indication was derived automatically from the Condition field of 2 registered trial(s). It reflects what is currently being studied, not a traditional use, and a curator should confirm the label is apt.

Literature

SR 0 · RCT 1 · preclinical 3

0 systematic review(s) and 1 RCT(s) were found. Size and consistency are not yet assessed.

Query used

We publish the exact query behind these counts so you can reproduce them yourself.

SRC:MED AND ((TITLE_ABS:"Rheum palmatum")) AND TITLE_ABS:"Sepsis"

Clinical trials

Safety

auto-proposed · unreviewed

  • 25 adverse-event or toxicity record(s) were found. This only flags that literature exists — read the abstracts to decide between "caution" and "harm confirmed".
  • 6 interaction-related record(s) are retrievable. This flags that literature exists — it is not an interaction checker (§3.4).
  • The KTKP record states the following traditional contraindication: 표증미해자(表證未解者), 혈허기약(血虛氣弱), 비위허한(脾胃虛寒), 무실열적체자(無實熱積滯者) 및태전산후(胎前産後)에는 복용을 기(忌)한다.

Adverse-event and toxicity literature

This is not a finding of harm — it lists literature that is retrievable. Read the papers to decide.

Interaction literature

This lists literature that is retrievable — it is not a judgement that an interaction exists. Read the papers to decide.

Sources

Bridges from here

In formulas
무극환